Medicaid Primary Care Improvement Act
Summary
The Medicaid Primary Care Improvement Act (S.3298) is a procedural, early-stage bill that clarifies states may use direct primary care arrangements in Medicaid but authorizes zero funding and mandates only guidance and a report. Near-term market impact on Medicaid MCOs is neutral. Recent 30-day rallies in MOH (+46%) and CNC (+62%) are driven by factors unrelated to this stalled legislation.
See which stocks are affected
Key takeaways, market implications, full AI analysis, and connected signals are available to HillSignal members.
Already have an account? Log in
Key Takeaways
- 1.S.3298 authorizes zero funding — it is purely permissive and procedural.
- 2.Bill has been stalled for 5 months with no committee action; single sponsor indicates minimal legislative momentum.
- 3.Recent 30-day rallies in MOH (+46%) and CNC (+62%) are driven by factors other than this bill.
- 4.No near-term operational or financial impact on any publicly traded company.
Market Implications
The recent price action in Medicaid MCOs reflects market catalysts entirely outside S.3298. MOH at $195.22 has more than doubled from its 52-week low of $121.06. CNC at $53.15 has more than doubled from its 52-week low of $25.08. Neither move correlates with the introduction or status of this stalled, funding-free bill. Investors should attribute any sector movement to other factors — earnings, policy changes with actual appropriations, or broader market rotation — not to S.3298.
Full Analysis
The Medicaid Primary Care Improvement Act (S.3298) was introduced on December 2, 2025 by Senator Blackburn (R-TN) and referred to the Senate Committee on Finance. No further action occurred in the 146 days since introduction. The bill's actual text clarifies that nothing in the Social Security Act prohibits states (including via MCOs) from using direct primary care arrangements — a permissive clarification, not a mandate. It authorizes $0 in funding, directs HHS to issue guidance within one year, and requires a report after two years. No appropriations are authorized or directed.
The money trail is absent: this bill sets no spending ceiling, creates no grant program, and provides no financial incentive for states to adopt direct primary care. It is an authorization of nothing more than administrative guidance. Actual adoption depends entirely on voluntary state action and subsequent appropriations.
Structural winners and losers are undefined at this stage because the bill produces no binding change. Medicaid MCOs (MOH, CNC) could theoretically see a long-term shift toward per-member-per-month direct primary care arrangements, but this is a legislative possibility years away requiring state-level adoption and regulatory clarity.
Real market data shows MOH at $195.22 and CNC at $53.15. MOH has rallied 46.44% in 30 days and 10.95% in the last week. CNC has surged 62.34% in 30 days and 27.09% in the last week. These moves are driven by factors entirely independent of S.3298 — likely broader sector sentiment, earnings expectations, or other legislative/regulatory catalysts. The bill itself contributed zero measurable impact.
Timeline: The bill must pass the Senate Finance Committee, the full Senate, the House, and be signed into law. Granting that, HHS would have one year to issue guidance and two years to report. No action has occurred for 5 months. Passage probability is low for a single-sponsor bill with no companion, no cosponsors, and no committee markup scheduled.
Intelligence Surface
Cross-referenced against federal contracts, SEC insider filings & congressional trade disclosures
No confirming evidence found yet from contracts, insider trades, or congressional activity
What the bill does
Permissive guidance and report on direct primary care arrangements under Medicaid, with no mandated change, no funding, and no penalty for non-compliance.
Who must act
State Medicaid agencies and Medicaid managed care organizations (MCOs) contracting with states under title XIX.
What happens
No near-term operational or financial requirement; potential long-term shift in primary care delivery model if states voluntarily adopt, but current early-stage legislation provides zero binding force.
Stock impact
Molina Healthcare operates Medicaid MCOs in multiple states; any future adoption of direct primary care could alter provider payment models and capitation structures, but present legislation imposes no change to MOH's existing contracts or revenue streams.
What the bill does
Permissive guidance and report on direct primary care arrangements under Medicaid, with no mandated change, no funding, and no penalty for non-compliance.
Who must act
State Medicaid agencies and Medicaid managed care organizations (MCOs) contracting with states under title XIX.
What happens
No near-term operational or financial requirement; potential long-term shift in primary care delivery model if states voluntarily adopt, but current early-stage legislation provides zero binding force.
Stock impact
Centene operates Medicaid MCOs across numerous states; any voluntary state adoption of direct primary care could affect Centene's network management and actuarial assumptions, but this bill mandates no action and provides no incentive, leaving current operations unchanged.
Connected Signals
Matched on shared policy language across AI analyses, with ticker & timing weight
Association Health Plans Act
Medicare for All Act
I CAN Act
Putting Patients First Healthcare Freedom Act
Metastatic Breast Cancer Access to Care Act
ANCHOR Act of 2025
ACO Assignment Improvement Act of 2025
To amend title XVIII of the Social Security Act to provide for certain reforms under the Medicare Advantage program, and for other purposes.
Related Presidential Actions
Executive orders & memoranda affecting the same sectors or companies
Implementing Schedule Policy/Career in the Excepted Service
This executive order expands the Schedule Policy/Career excepted service category, transferring certain federal positions from competitive service to at-will employment to facilitate removal for poor performance or misconduct. It directs agency heads to petition for reclassification of policy-influencing roles, mandates performance bonus pools for these employees, and amends civil service rules to exempt them from standard adverse action procedures.
Realigning United States Core Childhood Vaccine Recommendations with Best Practices from Peer, Developed Countries
This executive order directs the CDC and ACIP to review and potentially update the U.S. childhood vaccine schedule to align with recommendations from peer developed countries, which recommend fewer vaccines. It maintains insurance coverage for all currently available vaccines without cost sharing and emphasizes protecting religious liberty and parental authority.
Promoting Efficiency, Accountability, and Performance in Federal Contracting
This executive order mandates that federal agencies default to using fixed-price contracts for procurement, shifting away from cost-reimbursement models. It requires written justification and senior-level approval for any non-fixed-price contract over certain dollar thresholds (e.g., $10M for most agencies, $100M for the Department of War), and directs agencies to review and renegotiate their 10 largest non-fixed-price contracts within 90 days. The order also tasks OMB with implementation guidance and the Federal Acquisition Regulatory Council with proposing regulatory amendments within 120 days.